Results from a clinical trial led by researchers from Queen Mary University of London, published today in JAMA, show that ...

An oncology nurse shares advice for avoiding exhaustion and soreness when administering subcutaneous injections.

Bristol Myers on Wednesday said the European Commission approved the subcutaneous formulation of Opdivo for use across multiple adult solid tumors as monotherapy, monotherapy maintenance following ...

The extended injection time for subcutaneous daratumumab in those with myeloma can serve as an opportunity for oncology nurses to check in with patients.

A new treatment option for people with multiple sclerosis could alleviate resource strains on New Zealand's health system.

The injection takes just 3-5 min to administer, compared with 30-60 min ... This randomised, open-label phase 3 clinical trial compared subcutaneous and IV nivolumab in patients with previously ...

Vyvgart for subcutaneous injection is available as a vial or prefilled syringe and can be administered by a patient, caregiver, or healthcare professional. Treatment is initiated with a weekly dose ...

"We are delighted that the subcutaneous injection of VYVGART® co-formulated with our ENHANZE drug delivery technology, has been recommended for approval in the European Union. The positive CHMP ...

Hooven, Chairman and CEO of Enable Injections. “Our enFuse platform is uniquely positioned to address challenges in developing large-volume subcutaneous oncology drugs. This wearable delivery ...

Notably, this interview came following the Dec. 27, 2024, Food and Drug Administration (FDA) approval of the subcutaneous injection formulation of Opdivo for patients with solid tumors. Intravenous ...

For patients, for example, who had to previously travel long distances for IV treatments, they now may be able to receive these subcutaneous under the skin injections locally. Because Opdivo is now ...